亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Clinical Features of Recurrence After Hepatic Resection for Early-Stage Hepatocellular Carcinoma and Long-Term Survival Outcomes of Patients with Recurrence: A Multi-institutional Analysis

医学 肝细胞癌 外科肿瘤学 内科学 单变量分析 外科 肝硬化 阶段(地层学) 肝癌 多元分析 生物 古生物学
作者
Lan‐Qing Yao,Zhengliang Chen,Zihan Feng,Yong‐Kang Diao,Chao Li,Haiying Sun,Jian‐Hong Zhong,Ting‐Hao Chen,Wei‐Min Gu,Ya-Hao Zhou,Wanguang Zhang,Hong Zhang,Yongyi Zeng,Han Wu,Ming-Da Wang,Xin‐Fei Xu,Timothy M. Pawlik,Wan Yee Lau,Feng Shen,Tian Yang
出处
期刊:Annals of Surgical Oncology [Springer Science+Business Media]
卷期号:29 (7): 4291-4303 被引量:59
标识
DOI:10.1245/s10434-022-11454-y
摘要

BackgroundA potentially curative hepatic resection is the optimal treatment for hepatocellular carcinoma (HCC), but most HCCs, even at an early stage, eventually recur after resection. This study investigates clinical features of initial recurrence and long-term prognosis of patients with recurrence after curative resection for early-stage HCC.Patients and MethodsFrom a multicenter database, patients who underwent curative hepatic resection for early-stage HCC [Barcelona Clinic Liver Cancer (BCLC) stage 0/A] were extracted. Time to initial recurrence, patterns of initial recurrence, and treatment modalities for recurrent tumors were investigated. Univariate and multivariate analysis were used to identify independent risks associated with postoperative recurrence, as well as post-recurrence survival (PRS) for patients with recurrence.ResultsAmong 1424 patients, 679 (47.7%) developed recurrence at a median follow-up of 54.8 months, including 408 (60.1%) early recurrence (≤ 2 years after surgery) and 271 (39.9%) late recurrence (> 2 years). Independent risks of postoperative recurrence included cirrhosis, preoperative alpha-fetoprotein level > 400 ug/L, tumor size > 5 cm, multiple tumors, satellites, microvascular invasion, and intraoperative blood transfusion. Multivariate analysis revealed that receiving irregular recurrence surveillance, initial tumor beyond Milan criteria, early recurrence, BCLC stage B/C of the recurrent tumor, and noncurative treatments were independently associated with poorer PRS.ConclusionsNearly half of patients with early-stage HCC experienced recurrence after resection. Understanding recurrence risks may help identify patients at high risk of recurrence who may benefit from future adjuvant therapies. Meaningful survival even after recurrence can still be achieved by postoperative regular surveillance and curative treatment.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
15秒前
魔法师完成签到,获得积分0
18秒前
连安阳发布了新的文献求助10
20秒前
30秒前
连安阳完成签到,获得积分10
33秒前
EDTA完成签到,获得积分10
36秒前
cllcx发布了新的文献求助10
37秒前
cllcx完成签到,获得积分10
44秒前
小马哥完成签到,获得积分10
46秒前
52秒前
orixero应助忍蛙采纳,获得10
1分钟前
vera完成签到 ,获得积分10
1分钟前
nnnick完成签到,获得积分0
1分钟前
1分钟前
zzrg完成签到,获得积分10
1分钟前
NexusExplorer应助科研通管家采纳,获得10
2分钟前
科研通AI2S应助科研通管家采纳,获得10
2分钟前
2分钟前
2分钟前
忍蛙发布了新的文献求助10
2分钟前
ding应助乐悠悠采纳,获得15
2分钟前
ding应助香樟沐雪采纳,获得10
2分钟前
Evilw1an完成签到,获得积分10
2分钟前
劳健龙完成签到 ,获得积分10
2分钟前
善学以致用应助Evilw1an采纳,获得10
2分钟前
Explorer发布了新的文献求助50
3分钟前
在水一方应助百里幻竹采纳,获得10
3分钟前
烨枫晨曦完成签到,获得积分10
3分钟前
李爱国应助科研通管家采纳,获得10
4分钟前
4分钟前
4分钟前
4分钟前
百里幻竹发布了新的文献求助10
4分钟前
flyinthesky完成签到,获得积分10
4分钟前
小蘑菇应助高源源采纳,获得10
4分钟前
lizming关注了科研通微信公众号
4分钟前
HC完成签到,获得积分10
4分钟前
5分钟前
张晓祁完成签到,获得积分10
5分钟前
5分钟前
高分求助中
(应助此贴封号)【重要!!请各位详细阅读】【科研通的精品贴汇总】 10000
中国兽药产业发展报告 1000
Biodegradable Embolic Microspheres Market Insights 888
Quantum reference frames : from quantum information to spacetime 888
Pediatric Injectable Drugs 500
La RSE en pratique 400
ASHP Injectable Drug Information 2025 Edition 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4427365
求助须知:如何正确求助?哪些是违规求助? 3905279
关于积分的说明 12137259
捐赠科研通 3551274
什么是DOI,文献DOI怎么找? 1948790
邀请新用户注册赠送积分活动 988896
科研通“疑难数据库(出版商)”最低求助积分说明 884738